Expert Interviews

Dr. Deborah L. Benzil discusses her keynote address at AACS’s upcoming second annual Women in Cosmetic Surgery event, and uplifting women in medicine.

In the final part of our interview with Whitney Bowe, MD, she reveals her tips and tricks for both preventing and minimizing any adverse reactions in her filler patients who might have also received the COVID-19 vaccine.

In part 4 of our interview with Whitney Bowe, MD, she dives into the multiple methods physicians can use to treat adverse reactions from the COVID-19 vaccine in their dermal filler patients.

In part 3, Whitney Bowe, MD, suggests how physicians should manage their patients' expectations when it comes to HA fillers and the COVID-19 vaccine.

In the second part of our interview with Whitney Bowe, MD, she reveals the type of fillers that have been linked to adverse reactions in dermal filler patients who have received the COVID-19 vaccine.

In this expert interview, Whitney Bowe, MD, explains the rare adverse reactions the medical community has recently been seeing in dermal filler patients who received the COVID-19 vaccine.

Gary Salman, CEO, Black Talon Security, explains the best practices to incorporate in order to avoid a cyberattack.

Gary Salman, CEO, Black Talon Security, provides details on what to do if you encounter a data breach.

Dr. Fred Fedok explains his thoughts on a multi-dimensional approach to skin aging in his presentation at the 2020 AAFPRS virtual meeting.

Gary Salman, CEO, Black Talon Security, provides insights on how to avoid email breaches.

Find out what videos made the cut for our top five trending videos of 2020.

Dr. Stephen Perkins discusses the blepharoplasty techniques he uses to lower the risk of dry eye syndrome and chemosis.

Gary Salman, CEO, Black Talon Security, sits down with Dermatology Times to explain the risks of not having cybersecurity measures in place to protect yourself, your practice and your patients.

Gary Salman, CEO, Black Talon Security, explains why cybercriminals are now targeting dermatology and cosmetic surgery practices.

Dr. Parker A. Velargo discusses the potential risks and complications when performing intra-orbital buccal fat pad removal.

Key opinion leaders in dermatology share thoughts on unmet needs and the future direction of acne care.

During an informative discussion on current treatment options in acne, dermatology experts address the newly approved oral therapies sarecycline and micronized isotretinoin.

A panel of dermatology experts reviews the safety and efficacy data of the newly approved topical therapies trifarotene 0.005% cream, tazarotene 0.045% lotion, and minocycline 4% foam.

Dermatology experts comment on the safety and efficacy of the newly approved topical therapies clascoterone cream 1% and micronized tretinoin 0.05% lotion.

Key opinion leaders in dermatology discuss approaches to selecting treatment based on the pathophysiology of acne.

An overview of common sequelae and potential complications of acne, including physiological and psychological scaring.

Dermatology experts comment on the clinical manifestation of acne and the importance of differential diagnosis.

James Q. Del Rosso, DO, comments on the facts and myths surrounding contributory and predisposing factors that influence the development of acne.

Dermatologists discuss the impact of acne vulgaris on the quality of life experienced by their patients.

Julie C. Harper, MD, comments on the prevalence of acne in women and highlights differences from men.

As an introduction to a panel discussion on incorporating new medications into acne treatment, dermatology experts provide an overview of the who, what, and when of acne.

Dr. Jeffrey Joseph explains his approach to lower blepharoplasty, with a preference for the transconjunctival and orbicularis sling techniques.

Neelam Vashi, MD, FAAD, explains the results of her cross-sectional survey investigating melanoma awareness among different racial and ethnic groups.

In this monthly technology review, Dr. Michael Kluska examines Renuvion’s helium-based plasma technology by Apyx Medical, including device overview, cost, ROI, patient perceptions, and candidate considerations.